tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

MedAdvisor Limited Announces New Director Appointment

Story Highlights
  • MedAdvisor Limited operates in healthcare technology, enhancing medication management.
  • John Ciccio appointed as director, holding no current securities or contract interests.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
MedAdvisor Limited Announces New Director Appointment

Meet Your ETF AI Analyst

An announcement from MedAdvisor Limited ( (AU:MDR) ) is now available.

MedAdvisor Limited has announced the appointment of John Ciccio as a director, effective November 7, 2025. This announcement, detailed in the Initial Director’s Interest Notice, indicates that Ciccio currently holds no securities or interests in contracts related to the company. The appointment is part of MedAdvisor’s strategic efforts to strengthen its leadership team, potentially impacting its operational dynamics and stakeholder relations.

The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.

More about MedAdvisor Limited

MedAdvisor Limited operates in the healthcare technology industry, focusing on providing digital solutions to enhance medication management and adherence. The company primarily offers platforms and services that connect patients, pharmacies, and healthcare providers to improve health outcomes and streamline pharmaceutical care.

Average Trading Volume: 879,399

Technical Sentiment Signal: Sell

Current Market Cap: A$16.45M

See more insights into MDR stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1